Las Vegas, NV -- (SBWIRE) -- 12/11/2013 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: OCZ Technology Group Inc. (NASDAQ:OCZ), Navidea Biopharmaceuticals Inc (NYSEMKT:NAVB), Genco Shipping & Trading Limited (NYSE:GNK), Hemispherx BioPharma, Inc (NYSEMKT:HEB)
OCZ Technology Group Inc. (NASDAQ:OCZ) managed to keep its fall at -29.65% on above-normal volume of 8.43M shares. The stock settled at $0.0700 after floating in a range of $0.07 to $0.10. Its latest price has reached market capitalization of $4.77 million. Its 52-week range has been $0.07 to $2.77. OCZ Technology Group, Inc. (OCZ) designs, manufactures, and distributes solid-state drives (SSDs) and computer components. OCZ designs and manufactures SSDs in a variety of form factors and interfaces including Serial advanced technology attachment (SATA), serial-attached small computer system interface (SAS), peripheral component interconnect express (PCIe), as well as the development of flash management software, caching and virtualization software.
Has OCZ Found The Bottom and Ready To Move Up? Find Out Here
Navidea Biopharmaceuticals Inc (NYSEMKT:NAVB) traded up on a volume of 7.31 million, higher than its standard daily volume. Shares have gained 12.02% to $2.05. Over the last twelve months, the stock has gained 23.49% and faced a worst price of $1.11. Navidea Biopharmaceuticals, Inc. (Navidea), formerly Neoprobe Corporation, is a biopharmaceutical company focused on the development and commercialization of precision diagnostic agents. As of December 31, 2011, the Company’s radiopharmaceutical development programs included Lymphoseek (Lymphoseek, Kit for the Preparation of Technetium Tc99m for Injection), a radiopharmaceutical agent for lymph node mapping; AZD4694.
For How Long NAVB’s Gloss will Attract Investors? Find out via this report
Genco Shipping & Trading Limited (NYSE:GNK) settled -16.19% lower at $2.07 on above-normal volume of 7.02M shares during the last trading day. The stock has its 12-month high at $4.98 and 52-week low price was $1.12. It traded in a range of $1.64 to $2.09 during the last trading day. Genco Shipping & Trading Limited (GS&T) transports iron ore, coal, grain, steel products and other drybulk cargoes along worldwide shipping routes through the ownership and operation of drybulk carrier vessels. As of December 31, 2012, GS&T’s fleet consisted of 53 drybulk carriers, including nine capesize, eight panamax, 17 supramax, six handymax and 13 handysize drybulk carriers, with an aggregate carrying capacity of approximately 3,810,000 deadweight tonnages.
Will GNK Get Buyers Even After The Recent Rally? Find Out Here
In the last trading session, Hemispherx BioPharma, Inc (NYSEMKT:HEB) was down on high volume, trading at a volume of 6.73M versus its average daily volume of 1.16million shares. At $0.288, the stock has attained market capitalization of 48.29 million. Hemispherx Biopharma, Inc. (Hemispherx) is a specialty pharmaceutical company engaged in the clinical development of new drugs therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders. Hemispherx focuses on two core pharmaceutical technology platforms Ampligen and Alferon N Injection.
Why Should Investors Buy HEB After the Recent Fall? Just Go Here and Find Out
About Equity Observer:
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/" rel="nofollow" href="http://www.equityobserver.com/"> http://www.equityobserver.com/>
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)